The aim of treating childhood cancer remains to cure all. As survival rates improve, long-
term health outcomes increasingly define quality of care. The International Childhood …

Systemic combination chemotherapy and intrathecal chemotherapy markedly increased the
survival rate of children with ALL. In the past two decades, the use of minimal (measurable) …

Pancreatitis is a common and severe toxicity that occurs during asparaginase treatment for
acute lymphoblastic leukemia, and has received increasing attention during the last …

Acute lymphocytic leukemia (ALL) is a commonly diagnosed cancer in children. Despite
technological advancements to improve treatment and survival rates, there has been a …

Childhood leukemia accounts for 30% of all pediatric cancer cases with acute lymphoblastic
leukemia (ALL) being the most common subtype. Involvement of the gut microbiome in ALL …

This review paper will discuss the use of positron emission tomography/computed
tomography (PET/CT) in paediatric oncology. Functional imaging with PET/CT has proven …

A lot of attention is rightfully given to racial and socioeconomic disparities in cancer care. 1 It
is certain that disadvantaged groups have less access to lifeextending oncology care, with …

Objectives Asparaginase‐associated pancreatitis (AAP) occurs in up to 18% of patients
treated for acute lymphoblastic leukemia (ALL); however, long‐term sequelae are largely …

Introduction Optimal outcomes during childhood cancer treatment require effective
management of toxicities, often called supportive care. A lack of agreement on what …

Objective Investigate all‐cause and cause‐specific late mortality after childhood acute
lymphoblastic leukemia (ALL) in a population‐based Nordic cohort. Methods From the …